Skip to main content
Clinical Trials/NCT04438226
NCT04438226
Completed
Not Applicable

Surgical Approach of Hemiarthroplasty After Femoral Neck Fracture: Posterolateral or Direct Lateral

JointResearch1 site in 1 country555 target enrollmentDecember 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Fractures
Sponsor
JointResearch
Enrollment
555
Locations
1
Primary Endpoint
EQ-5D-5L
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Rationale: In the Netherlands the two main surgical approaches for hemiarthroplasty are the posterolateral and the direct lateral approach. Currently there is no conclusive evidence which of these two approaches results in better patient outcomes.

Objective: Assessing the patient outcome comparing the posterolateral with the direct lateral approach in patients being treated with cemented hemiarthroplasty after femoral neck fractures.

Study design: A randomised controlled multi-center superiority trial and natural experiment with an economic evaluation alongside.

Study population: All patients older than 18 years with a femoral neck fracture whereby treatment with cemented hemiarthroplasty is recommended according the national guidelines.

Intervention: Treatment with cemented hemiarthroplasty using the posterolateral approach.

Standard intervention to be compared to: Treatment with cemented hemiarthroplasty using the direct lateral approach.

Main study parameters/endpoints: The primary outcome is the patient-rated quality of life (EQ-5D-5L) at 6 months after surgery.

Secondary outcomes are: ADL functionality (KATZ), Balance test (SPPB), Tendency to Fall (FES-I), Pain (NRS), Re-interventions, Mobility, Discharge destination, Complications, and cost-effectiveness.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The different approaches in the two treatment arms of the randomised controlled trial are widely used techniques in the Netherlands and many of the outcome measures are part of the standard clinical follow-up after hip fracture. Therefore, there is no extra risk or burden for participating patients, except for the time to complete some additional follow-up measurements. The primary outcome measurement and secondary outcomes, will be assessed through questionnaires online, by hardcopy or by phone at baseline, 4 weeks, 3 and 6 months postoperatively. The assessment of the Short Physical Performance Battery (SPPB) balance test, will be performed by one of the study researchers or nurse practitioner to protect continuity and feasibility.

Registry
clinicaltrials.gov
Start Date
December 1, 2017
End Date
July 7, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
JointResearch
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥ 18 years at time of trauma
  • Acute hip fracture
  • Hemiarthroplasty as recommended treatment according the national guidelines
  • Dutch or English fluency and literacy
  • Informed consent or by proxy in patients with mental impairment

Exclusion Criteria

  • Multi-trauma-patient (ISS \> 15)
  • Secondary surgery after failed internal fixation
  • Patients with a known metastatic disease and a confirmed pathological fracture of the hip
  • Fracture \> 7 days at time of surgery
  • High risk of non-compliance/adherence to study procedures (e.g. no Dutch residency during follow-up period, or other factors that impair follow-up data collection)

Outcomes

Primary Outcomes

EQ-5D-5L

Time Frame: at 6 months after surgery

The EQ-5D-5L descriptive system assesses health in five dimensions (MOBILITY, SELF-CARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY / DEPRESSION), each of which has five levels of response (no problems, slight problems, moderate problems, severe problems, extreme problems/unable to). This part of the EQ-5D questionnaire provides a descriptive profile that can be used to generate a health state profile. Health state index scores generally range from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility. The second part of the questionnaire consists of a visual analogue scale (VAS) on which the patient rates his/her perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).

Secondary Outcomes

  • KATZ(at 6 months after surgery)
  • Mobility(at 6 months after surgery)
  • Complications(During admission, 3 and 6 months post-operative)
  • Discharge destination(After admission, at 3 and 6 months post-operative)
  • SPPB(at 4 months after surgery)
  • NRS(at 6 months after surgery)
  • Re-interventions(at 6 months after surgery)
  • FES-I(at 6 months after surgery)
  • Cost-effectiveness(at 4 weeks, 3 and 6 months post-operative)

Study Sites (1)

Loading locations...

Similar Trials